Page 1

MD Health NEWS RELEASE - REGULATED INFORMATION 26 AUGUST 2021 , 18:00 CET MDxHealth Reports Half Year 2021 Results Conference call with Q & A today at 19:00 CET / 1PM US ET , details provided below IRVINE , CA , and HERSTAL , BELGIUM - August 26 , 2021 – MDxHealth SA ( Euronext : MDXH.BR ) , a commercial- stage precision diagnostics company , today announced its financial results for the half year ended June 30 , 2021 . Michael K. McGarrity , CEO of MDxHealth , commented : “ We are encouraged by our positive progress in the first half of 2021. Our results reflect our confidence that the key fundamentals of our business are in place and will drive sustained growth for MDxHealth . " We believe this progress is evidenced by the following : Publication of draft foundational Local Coverage Determination ( LCD ) for Biomarkers to Stratify Patients at Increased Risk for Prostate Cancer by Palmetto GBA under its MolDx program , which cites evidence of the clinical utility of SelectMDXⓇ and , when finalized , is expected to support coverage for qualified Medicare patients throughout the United States ; • Third consecutive quarter of sequential increases in billable volume for our Confirm MDxⓇ test , second consecutive quarter of sequential increases in billable volume for our SelectMDxⓇ test ; • Improvement in collections and capital allocation , supported by continued focus on operating discipline ; and Advancement of development programs to expand our Prostate Cancer menu into Active Surveillance . " In addition to positive results for our menu of SelectMDx and ConfirmMDx , at the conclusion of the half year , we made a Urinary Tract Infection ( UTI ) diagnostic panel available to a limited number of urology practices , as our first channel opportunity into urology , where approximately 20 % of the 10 million UTI patients present in the U.S. annually . As we have stated , we have restructured our sales and overall commercial team to not only drive growth of our core and expanding prostate cancer menu , but to also take advantage of additional opportunities to serve our customer base and leverage this channel . " Highlights for the half year and quarter ended June 30 , 2021 • • • • H1-2021 services revenue of $ 10.5 million , up 9 % as compared to $ 9.6 million in H1-2020 ; Q2-2021 services revenue up 43 % from Q2-2020 H1-2021 ConfirmMDx billable test volume increased 4 % to 7,978 versus 7,662 for the same period last year ; Q2-2021 up 30 % from Q2-2020 and 4 % sequentially from Q1-2021 H1-2021 SelectMDx billable test volume increased 9 % to 7,051 versus 6,462 for the same period last year ; Q2-2021 up 82 % from Q2-2020 and 16 % sequentially from Q1-2021 Cash balance as of June 30 , 2021 was $ 31.3 million ; cash use in H1-2021 was $ 13.1 million , an increase of $ 0.2 million , or 1 % , versus cash use in H1-2020 Successful financing of € 25 million ( approximately $ 30 million ) , with broad support from U.S. and European investors including continued support from our Reference shareholders , MVM , Valiance and BioVest